Dagna L - Search Results

1

Tocilizumab in patients with multisystem Erdheim-Chester disease.

Berti A, Cavalli G, Guglielmi B, Biavasco R, Campochiaro C, Tomelleri A, Nicoletti R, Panzacchi A, Ferrarini M, Dagna L. Berti A, et al. Among authors: dagna l. Oncoimmunology. 2017 Apr 20;6(6):e1318237. doi: 10.1080/2162402X.2017.1318237. eCollection 2017. Oncoimmunology. 2017. PMID: 28680751 Free PMC article.

2

Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.

Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR. Ferrarini M, et al. Among authors: dagna l. Trends Immunol. 2002 Jan;23(1):14-8. doi: 10.1016/s1471-4906(01)02110-x. Trends Immunol. 2002. PMID: 11801449 Review.

3

Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 gamma delta T lymphocytes.

Dagna L, Iellem A, Biswas P, Resta D, Tantardini F, Fortis C, Sabbadini MG, D'Ambrosio D, Manfredi AA, Ferrarini M. Dagna L, et al. Eur J Immunol. 2002 Oct;32(10):2934-43. doi: 10.1002/1521-4141(2002010)32:10<2934::AID-IMMU2934>3.0.CO;2-6. Eur J Immunol. 2002. PMID: 12355447 Free article.

4

A relapsing inflammatory syndrome and active human herpesvirus 8 infection.

Dagna L, Broccolo F, Paties CT, Ferrarini M, Sarmati L, Praderio L, Sabbadini MG, Lusso P, Malnati MS. Dagna L, et al. N Engl J Med. 2005 Jul 14;353(2):156-63. doi: 10.1056/NEJMoa042850. N Engl J Med. 2005. PMID: 16014885 Free article.

5

Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis.

Dagna L, Girlanda S, Langheim S, Rizzo N, Bozzolo EP, Sabbadini MG, Ferrarini M. Dagna L, et al. Rheumatology (Oxford). 2010 Jun;49(6):1203-6. doi: 10.1093/rheumatology/kep461. Epub 2010 Jan 22. Rheumatology (Oxford). 2010. PMID: 20097905 No abstract available.

6

Erdheim-Chester disease: imaging-guided therapeutic approach.

Della Torre E, Dagna L, Mapelli P, Mellone R, Grazia Sabbadini M. Della Torre E, et al. Among authors: dagna l. Clin Nucl Med. 2011 Aug;36(8):704-6. doi: 10.1097/RLU.0b013e318217ade7. Clin Nucl Med. 2011. PMID: 21716027

7

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.

Dagna L, Corti A, Langheim S, Guglielmi B, De Cobelli F, Doglioni C, Fragasso G, Sabbadini MG, Ferrarini M. Dagna L, et al. J Clin Oncol. 2012 Oct 1;30(28):e286-90. doi: 10.1200/JCO.2012.41.9911. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869874 No abstract available.

8

The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases.

Cavalli G, Guglielmi B, Berti A, Campochiaro C, Sabbadini MG, Dagna L. Cavalli G, et al. Among authors: dagna l. Ann Rheum Dis. 2013 Oct;72(10):1691-5. doi: 10.1136/annrheumdis-2012-202542. Epub 2013 Feb 8. Ann Rheum Dis. 2013. PMID: 23396641 Review.

9

Diagnosing Erdheim-Chester disease.

Cavalli G, Berti A, Campochiaro C, Dagna L. Cavalli G, et al. Among authors: dagna l. Ann Rheum Dis. 2013 Jul;72(7):e19. doi: 10.1136/annrheumdis-2013-203685. Epub 2013 Apr 16. Ann Rheum Dis. 2013. PMID: 23592711 No abstract available.

10

Assessment of tocilizumab in the treatment of cancer cachexia.

Berti A, Boccalatte F, Sabbadini MG, Dagna L. Berti A, et al. Among authors: dagna l. J Clin Oncol. 2013 Aug 10;31(23):2970. doi: 10.1200/JCO.2012.48.4147. Epub 2013 Jul 1. J Clin Oncol. 2013. PMID: 23816970 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters